Surgical Augmentation of the Suprachoroidal Space: A Novel Material and Implant

References

• Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. 2017;390(10108):2183–2193. PMID: 28577860. doi:10.1016/S0140-6736(17)31469-1
   PubMed Web of Science ®Google Scholar
• Heijl A. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol. 2002;120(10):1268. doi:10.1001/archopht.120.10.1268
   PubMed Web of Science ®Google Scholar
• Agis Investigators. The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429–440. doi:10.1016/S0002-9394(00)00538-9
   PubMed Web of Science ®Google Scholar
• Saheb H, Ahmed IIK. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23(2):96–104. doi:10.1097/ICU.0b013e32834ff1e7
   PubMed Web of Science ®Google Scholar
• European Glaucoma Society. Terminology and Guidelines for Glaucoma. 5th ed. 2020.
   Google Scholar
• De Francesco T, Ahmed IIK. An overview on options in glaucoma surgery. Glaucoma Now; 2021.
   Google Scholar
• Moisseiev E, Loewenstein A, Yiu G. The suprachoroidal space: from potential space to a space with potential. Clin Ophthalmol. 2016;10:173–178. PMID: 26869750; PMCID: PMC4734808. doi:10.2147/OPTH.S89784
   PubMed Web of Science ®Google Scholar
• Toris CB, Yablonski ME, Wang Y-L, Camras CB. Aqueous humor dynamics in the aging human eye. Am J Ophthalmol. 1999;127(4):407–412. doi:10.1016/S0002-9394(98)00436-X
   PubMed Web of Science ®Google Scholar
• Weinreb RN. Uveoscleral outflow: the other outflow pathway. J Glaucoma. 2000;9(5):343–345. doi:10.1097/00061198-200010000-00001
   PubMed Web of Science ®Google Scholar
• Bill A, Phillips CI. Uveoscleral drainage of aqueous humour in human eyes. Exp Eye Res. 1971;12(3):275–281. doi:10.1016/0014-4835(71)90149-7
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Toris CB, Gabelt BT, Lindsey JD, Kaufman PL. Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol. 2002;47:S53–S64. doi:10.1016/S0039-6257(02)00306-5
   PubMed Web of Science ®Google Scholar
• Shaarawy T, Gigon A. The suprachoroidal route in glaucoma surgery. J Curr Glaucoma Pract. 2016;10(1):13–20. doi:10.5005/jp-journals-10008-1197
   PubMedGoogle Scholar
• Bill A. Effects of atropine and pilocarpine on aqueous humour dynamics in cynomolgus monkeys (Macaca irus). Exp Eye Res. 1967;6(2):120–125. PMID: 4960736. doi:10.1016/s0014-4835(67)80062-9
   PubMed Web of Science ®Google Scholar
• Emami-Naeini P, Yiu G. Medical and surgical applications for the suprachoroidal space. Int Ophthalmol Clin. 2019;59(1):195. doi:10.1097/IIO.0000000000000251
   PubMedGoogle Scholar
• Bryce C, Hwan Jung J, Prausnitz MR. The suprachoroidal space as a route of administration to the posterior segment of the eye. Adv Drug Deliv Rev. 2018;126:58–66. doi:10.1016/j.addr.2018.03.001
   PubMed Web of Science ®Google Scholar
• Figus M, Posarelli C, Passani A, et al. The supraciliary space as a suitable pathway for glaucoma surgery: ho-hum or home run? Surv Ophthalmol. 2017;62(6):828–837. doi:10.1016/j.survophthal.2017.05.002
   PubMed Web of Science ®Google Scholar
• Heine L. Die Cyclodialyse, eine neuen Glaukomoperation. Med Wochenschr. 1905;31:824–826.
   Google Scholar
• Goldmann H. Uber die wirkungsweise der cyclodialyse. Ophthalmologica. 1951;121:94–100. doi:10.1159/000300942
   PubMed Web of Science ®Google Scholar
• García-Feijoo J, Rau M, Grisanti S, et al. Supraciliary micro-stent implantation for open-angle glaucoma failing topical therapy: 1-year results of a multicenter study. Am J Ophthalmol. 2015;159(6):1075–1081.e1. PMID: 25747677. doi:10.1016/j.ajo.2015.02.018
   PubMed Web of Science ®Google Scholar
• Vold S, Ahmed II, Craven ER, et al; CyPass Study Group. Two-year COMPASS Trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology. 2016;123(10):2103–2112. PMID: 27506486. doi:10.1016/j.ophtha.2016.06.032
   PubMed Web of Science ®Google Scholar
• Lass JH, Benetz BA, He J, et al. Corneal endothelial cell loss and morphometric changes 5 years after phacoemulsification with or without CyPass micro-stent. Am J Ophthalmol. 2019;208:211–218. PMID: 31377278. doi:10.1016/j.ajo.2019.07.016
   PubMed Web of Science ®Google Scholar
• Grierson I, Minckler D, Rippy MK, et al. A novel suprachoroidal microinvasive glaucoma implant: in vivo biocompatibility and biointegration. BMC Biomed Eng. 2020;2(1):10. doi:10.1186/s42490-020-00045-1
   PubMedGoogle Scholar
• Denis P, Hirneiß C, Reddy KP, et al. A first-in-human study of the efficacy and safety of MINIject in patients with medically uncontrolled open-angle glaucoma (STAR-I). Ophthalmol Glaucoma. 2019;2(5):290–297. doi:10.1016/j.ogla.2019.06.001
   PubMedGoogle Scholar
• Martin MJ, Summer A, Gold EB, et al. Race and primary open-angle glaucoma. Am J Ophthalmol. 1985;99(4):383–387. doi:10.1016/0002-9394(85)90001-7
   PubMed Web of Science ®Google Scholar
• García Feijoó J, Denis P, Hirneiß C, et al. A European study of the performance and safety of MINIject in patients with medically uncontrolled open-angle glaucoma (STAR-II). J Glaucoma. 2020;29(10):864–871. doi:10.1097/IJG.0000000000001632
   PubMed Web of Science ®Google Scholar
• Denis P, Hirneiß C, Durr GM, et al. Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial. Br J Ophthalmol. 2022;106(1):65–70. doi:10.1136/bjophthalmol-2020-316888
   PubMed Web of Science ®Google Scholar
• Ahmed I Three-year results of a supraciliary drainage device in patients with open angle glaucoma. Virtually Hosted by Japan Glaucoma Society Paper Presentation.: World Glaucoma E-Congress, 30 June; 2021.
   Google Scholar
• Singh I, Denis P, Hirneiß C, et al. A European study of the efficacy and safety of a supraciliary glaucoma drainage device in patients with open angle glaucoma (STAR-II). Paper Presentation: American Academy of Ophthalmology Meeting, 15 November; 2021; New Orleans, Louisiana: Ernest N Morial Convention Center.
   Google Scholar
• Zi-Yan Y, Wu L, Qu B, et al. Changes in corneal endothelial cell density in patients with primary open-angle glaucoma. World J Clin Cases. 2019;7(15):1978–1985. doi:10.12998/wjcc.v7.i15.1978
   PubMed Web of Science ®Google Scholar
• Kim KN, Lee SB, Lee YH, et al. Changes in corneal endothelial cell density and the cumulative risk of corneal decompensation after Ahmed glaucoma valve implantation. Br J Ophthalmol. 2016;100(7):933–938. doi:10.1136/bjophthalmol-2015-306894
   PubMed Web of Science ®Google Scholar
• Cho SW, Kim JM, Choi CY, et al. Changes in corneal endothelial cell density in patients with normal-tension glaucoma. Jpn J Ophthalmol. 2009;53(6):569–573. doi:10.1007/s10384-009-0740-1
   PubMed Web of Science ®Google Scholar
• Setälä K. Corneal endothelial cell density after an attack of acute glaucoma. Acta Ophthalmol. 2009;57(6):1004–1013. doi:10.1111/j.1755-3768.1979.tb00531.x
   Google Scholar
• Summary of safety and effectiveness data compass data. The FDA; 2016. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf15/P150037B.pdf. Accessed November 8, 2021.
   Google Scholar
• Summary of safety and effectiveness data Hydrus data. The FDA; 2018. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170034B.pdf. Accessed November 8, 2021.
   Google Scholar
• Summary of safety and effectiveness data iSTENT data. The FDA; 2018. Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf17/P170043B.pdf. Accessed November 8, 2021.
   Google Scholar
• Oddone F, Roberti G, Posarelli C, et al. Endothelial cell density after XEN implant surgery: short-term data from the Italian XEN glaucoma treatment registry (XEN-GTR). J Glaucoma. 2021;30:559–565. doi:10.1097/IJG.0000000000001840
   PubMed Web of Science ®Google Scholar